医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
4-异丁基吡啶 | 4-isobutylpyridine | 4810-79-1 | C9H13N |
|
4-己基噻吩-2-甲腈 | 4-hexylthiophene-2-carbonitrile | 1224430-39-0 | C11H15NS |
|
4-己基-2-噻吩硼酸频哪醇酯 | 2-(4-hexylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 883742-29-8 | C16H27BO2S |
|
4-巯基嘧啶 | 4(3H)-pyrimidinethione | 1450-86-8 | C4H4N2S |
|
4-巯乙基吡啶 | 2-(pyridin-4-yl)ethanethiol | 2127-05-1 | C7H9NS |
|
4-安替比林甲醛 | 4-formyl-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one | 950-81-2 | C12H12N2O2 |
|
4-噻吩-2-基-噻唑-2-胺 | 2-amino-4-(2-thienyl)thiazole | 28989-50-6 | C7H6N2S2 |
|
4-嘧啶羰酰氯 | pyrimidine-4-carbonyl chloride | 184951-32-4 | C5H3ClN2O |
|
4-嘧啶甲酸钠盐 | sodium pyrimidine-4-carboxylate | 819850-18-5 | C5H3N2O2*Na |
|
4-嘧啶甲酸乙酯 | ethyl pyrimidine-4-carboxylate | 62846-82-6 | C7H8N2O2 |
|
4-嘧啶甲酸 | pyrimidine-4-carboxylic acid | 31462-59-6 | C5H4N2O2 |
|
4-嘧啶甲脒 | Pyrimidine-4-carboximidamide | 738575-71-8 | C5H6N4 |
|
4-嘧啶甲胺盐酸盐 | Pyrimidin-4-ylmethanamine dihydrochloride | 618446-08-5 | C5H9Cl2N3 |
|
4-嘧啶基-5-苯甲酸乙酯 | 4-(pyrimidin-5-yl)benzoic acid ethyl ester | 82525-18-6 | C13H12N2O2 |
|
4-嘧啶基-2-苯胺 | 4-(pyrimidin-2-yl)aniline | 69491-57-2 | C10H9N3 |
|
4-嘧啶基-2-苯甲酰胺 | 4-pyrimidin-2-ylbenzylamine | 885466-44-4 | C11H11N3 |
|
4-嘧啶基-2-苯甲酰氯 | 4-pyrimidin-2-yl-benzoyl chloride | 679806-84-9 | C11H7ClN2O |
|
4-嘧啶乙酸乙酯 | ethyl 2-(pyrimidin-4-yl)acetate | 1240606-58-9 | C8H10N2O2 |
|
4-嘧啶乙酸 | 2-(pyrimidin-4-yl)acetic acid | 325491-53-0 | C6H6N2O2 |
|
4-喹啉羰酰氯 | quinolone-4-carbonyl chloride | 50821-72-2 | C10H6ClNO |
|
4-喹啉羧酸甲酯 | quinoline-4-carboxylic acid methyl ester | 21233-61-4 | C11H9NO2 |
|
4-喹啉磺酸 | quinoline-4-sulfonic acid | 6046-42-0 | C9H7NO3S |
|
4-喹啉甲醛 | quinoline-4-carboxaldehyde | 4363-93-3 | C10H7NO |
|
4-喹啉甲醇 | 4-quinolylmethanol | 6281-32-9 | C10H9NO |
|
4-喹啉甲酸 | 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid | 88569-39-5 | C11H8ClFN2O3 |
|
4-喹啉乙酸 | [4]quinolyl-acetic acid | 109922-57-8 | C11H9NO2 |
|
4-喹啉丙酸 | 4-quinolinylpropanoic acid | 67752-29-8 | C12H11NO2 |
|
4-喹啉-羧酰胺 | quinoline-4-carboxamide | 4363-95-5 | C10H8N2O |
|
4-喹唑啉酮-2-甲酸乙酯 | ethyl 4-oxo-3,4-dihydro-2-quinazolinecarboxylate | 29113-33-5 | C11H10N2O3 |
|
4-喹唑啉酮-2-甲酸 | 4-oxo-3,4-dihydroquinazoline-2-carboxylic acid | 29113-34-6 | C9H6N2O3 |
|
4-哒嗪胺盐酸盐(1:1) | pyridazin-4-amine hydrochloride | 1400764-35-3 | C4H5N3*ClH |
|
4-哒嗪羧酸 | pyridazine-4-carboxylic acid | 50681-25-9 | C5H4N2O2 |
|
4-哒嗪甲醇 | 4-hydroxymethylpyridazine | 50901-43-4 | C5H6N2O |
|
4-哒嗪乙酸锂盐 | Lithium 2-(pyridazin-4-yl)acetate | 1217295-84-5 | C6H5LiN2O2 |
|
4-哌嗪苯甲酸 | 4-piperidin-1-yl-benzoic acid | 22090-24-0 | C12H15NO2 |
|
4-哌嗪苯乙酮 | 4'-piperazinoacetophenone | 51639-48-6 | C12H16N2O |
|
4-哌嗪基苯胺 | 4-(piperazin-1-yl)aniline | 67455-41-8 | C10H15N3 |
|
4-哌嗪基苯甲腈 | 1-(4-Cyanophenyl)piperazine | 68104-63-2 | C11H13N3 |
|
4-哌嗪基苯并噻吩盐酸盐 | 1-(benzo[b]thiophen-4-yl)piperazine | 846038-18-4 | C12H14N2S |
|
4-哌嗪四氢-1(2H)-吡啶羧酸叔丁酯 | tert-butyl 4-(piperazin-1-yl)piperidine-1-carboxylate | 177276-41-4 | C14H27N3O2 |
|
4-哌嗪哌啶 | 1-(4-piperidinyl)piperazine | 142013-66-9 | C9H19N3 |
|
4-哌嗪-1-基喹啉 | 4-piperazinylquinoline | 118306-89-1 | C13H15N3 |
|
4-哌啶酮缩乙二醇 | 4,4-ethylenedioxy-piperidine | 177-11-7 | C7H13NO2 |
|
4-哌啶甲酸叔丁酯 | 4-tert-butyl piperidine-4-carboxylate | 138007-24-6 | C10H19NO2 |
|
4-哌啶基哌啶 | 4-piperidinopiperidin | 4897-50-1 | C10H20N2 |
|
4-哌啶乙酸乙酯 | ethyl (piperidin-4-yl)acetate | 59184-90-6 | C9H17NO2 |
|
4-哌啶乙酰胺盐酸盐 | 4-piperidineacetamide | 184044-10-8 | C7H14N2O |
|
4-哌啶-4-基甲基吡啶二盐酸盐 | 4-(Piperidin-4-ylmethyl)pyridine dihydrochloride | 1172465-66-5 | C11H18Cl2N2 |
|
4-呋喃-7-羟基甲基喹啉 | 4-Furan-3-YL-7-hydroxymethylquinoline | 168154-44-7 | C14H11NO2 |
|
4-吡啶醛 N-氧化物 | isonicotinaldehyde 1-oxide | 7216-42-4 | C6H5NO2 |
|